Claritev Selected by GDIT to Support CDC’s World Trade Center Health Program
Claritev Selected by GDIT to Support CDC’s World Trade Center Health Program
Claritev will support General Dynamics Information Technology by providing the Nationwide Provider Network for World Trade Center Responders and Survivors
Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, has been selected by General Dynamics Information Technology (GDIT) to support the World Trade Center (WTC) Health Program. The WTC Health Program is a limited federal health care program established under the James Zadroga 9/11 Health and Compensation Act of 2010 (Extended in 2015). It provides nationwide medical monitoring and treatment to responders and survivors of the events of September 11, 2001.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922257331/en/
As part of GDIT’s team, Claritev will leverage its existing provider network to administer the Nationwide Provider Network (NPN), ensuring members across the country have access to available, high-quality healthcare. Claritev’s extensive network will connect Survivors and Responders who reside outside of the New York metropolitan area with healthcare providers experienced in diagnosing and treating unique conditions related to 9/11 exposures.
“Claritev is honored to contribute to such a meaningful program that continues to service those affected by the events of September 11,” said Travis Dalton, CEO and President of Claritev. “Our extensive provider network and decades of healthcare data experience position us to ensure that every WTC Health Program member has access to the care they deserve, no matter where they now live.”
Claritev’s role will focus on network development, credentialing, and maintaining provider access across the country for members who reside outside of the New York metropolitan area to receive care for their certified WTC-related health conditions.
About Claritev
Claritev is a healthcare technology, data, and insights company focused on delivering affordability, transparency, and quality across the U.S. healthcare system. Led by deeply experienced associates, data scientists, and innovators, Claritev provides technology-enabled solutions fueled by decades of claims expertise. The company leverages advanced analytics and AI to power a robust enterprise platform that delivers clear, actionable insights to support affordability, price transparency, and optimized network and benefits design. By supporting key stakeholders — including payers, employers, patients, providers, and third parties — Claritev is dedicated to making healthcare more accessible and affordable for all.
Claritev serves more than 750 healthcare payers, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit claritev.com.
Media
Jen O’Connor
VP, Brand Marketing
press@claritev.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260922257331/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
5 Stocks to Sell for Tax-Loss Harvesting
33 Undervalued Stocks to Buy Before the Market Shifts Again
Ask the Analyst: What Is the Best Source for Low-Risk Tax-Free Income?
The Smartest Moves for Bond Investors Today, and What to Do When You Have Too Many Investments
United States